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Abstract
B cell and plasma cell responses take place in lymphoid organs, but because of the inaccessibility of these organs, analyses
of human responses are largely performed using peripheral blood mononuclear cells (PBMC). To determine whether PBMC
are a useful source of memory B cells and plasma cells in malaria, and whether they reflect Plasmodium-specific B cell
responses in spleen or bone marrow, we have investigated these components of the humoral response in PBMC using a
model of Plasmodium chabaudi blood-stage infections in C57BL/6 mice. We detected memory B cells, defined as isotype-
switched IgD
2 IgM
2 CD19
+ B cells, and low numbers of Plasmodium chabaudi Merozoite Surface Protein-1 (MSP1)-specific
memory B cells, in PBMC at all time points sampled for up to 90 days following primary or secondary infection. By contrast,
we only detected CD138
+ plasma cells and MSP1-specific antibody-secreting cells within a narrow time frame following
primary (days 10 to 25) or secondary (day 10) infection. CD138
+ plasma cells in PBMC at these times expressed CD19, B220
and MHC class II, suggesting that they were not dislodged bone-marrow long-lived plasma cells, but newly differentiated
migratory plasmablasts migrating to the bone marrow; thus reflective of an ongoing or developing immune response. Our
data indicates that PBMC can be a useful source for malaria-specific memory B cells and plasma cells, but extrapolation of
the results to human malaria infections suggests that timing of sampling, particularly for plasma cells, may be critical.
Studies should therefore include multiple sampling points, and at times of infection/immunisation when the B-cell
phenotypes of interest are likely to be found in peripheral blood.
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Introduction
The majority of the human cellular immunological studies are
performed using peripheral blood mononuclear cells, as blood is,
with a few exceptions [1] the only readily accessible source of cells
of the innate and acquired immune system. However during and
after infections, particularly long-lasting infections such as malaria,
a redistribution of lymphocytes can take place where specific
lymphocytes become activated and remain in lymphoid organs or
migrate to the tissues rather than circulate in peripheral blood.
Thus low, or no, specific responses in peripheral blood may not
necessarily imply that the host is hypo-responsive. This makes it
difficult to interpret human cellular studies. For example, it has
been demonstrated that activated antigen-specific T cells are
transiently depleted from the circulation at the peak of infection
with P. falciparum [2–6]. However, in P. chabaudi infection, specific
CD4
+ T cell responses were detected in peripheral blood
mononuclear cells (PBMC) at late time points after the
parasitaemia had been cleared [5]. This suggests that T cell
responses in peripheral blood may not necessarily be indicators of
the immune responses occurring in lymphoid organs, and that
timing the sampling of PBMC from infected individuals may be
important to catch responsive T cells.
Much less is known about alterations in the distribution of B cell
and plasma cell populations following malaria infection. Since B
cell and antibody responses are crucial for protective immunity to
blood-stage malaria infections [7–10], it is important to under-
stand their nature and regulation. Some studies have shown that B
cell numbers are altered in the spleens of mice during blood-stage
malaria infection [11], and two reports suggest that B cell subset
redistribution also occurs in humans [12,13]. The changes in the
composition and distribution of B cells and plasma cells which
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infection [14–19] may be detected in peripheral blood as memory
B cells (MBC) and plasma cells can circulate or migrate between
lymphoid compartments during an ongoing humoral response. A
recent study has shown that the spleen, but not blood, is a major
reservoir for human virus-specific memory B cells [1]. This
information is not available for human malaria.
Experimental models may provide an indication of the
usefulness of peripheral blood PBMC as a source of B cells and
plasma cells in malaria infections. Here, we have used a mouse
model of malaria, Plasmodium chabaudi chabaudi (AS) in C57BL/6
mice, and flow cytometry and ELISpot assays, to compare B cell
and plasma cell responses in PMBC with those in the spleen
(where B cells are activated) and bone marrow (BM) (where
haematopoesis leading to production of B cells occurs; and where
the majority of long-lived plasma cells reside) during acute
malaria infection, to determine whether B cell responses observed
in peripheral blood reflect those observed in the other organs,
and if it reflects a malaria-specific B cell response. We found that
memory B cells were present in the blood in low numbers at all
time points tested for up to 90 days following infection, and
Merozoite Surface Protein 1 (MSP1)-specific memory B cells
could be detected by ELISpot at these times. In contrast, plasma
cells and MSP1-specific antibody-secreting cells (ASC) were
detectable in blood only within a narrow time period,
approximately 10 days following infection. These ASC were
likely to reflect a developing plasma cell response, as the majority
of CD138
+ cells in the blood at this time had the characteristics of
newly differentiated migratory plasmablasts rather than mature
long-lived plasma cells that had been dislodged from the bone
marrow.
The results from this comparative study suggest that timing of
blood sampling following a malaria infection may be crucial for
the detection of antigen-specific B cell responses in peripheral
blood.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the UK
Animals (Scientific Procedures) Act 1986. This study was approved
by the Ethics Committee of the MRC National Institute for
Medical Research, and the British Home Office (PPL: 80/2538).
Mice
Female C57BL/6 mice aged 6–8 weeks were obtained from the
specific pathogen free unit at the National Institute for Medical
Research (NIMR), London. For experimental purposes, mice were
housed conventionally with sterile bedding, food and irradiated
water.
Infection with P. chabaudi chabaudi (AS) parasites
A cloned line of Plasmodium chabaudi. chabaudi (AS) originally
obtained from David Walliker, University of Edinburgh was used
in this study. Stabilates were cryopreserved in blood from C57BL/
6 mice. To obtain parasites for experimental infection, an aliquot
of the stabilate was injected intraperitoneally into donor C57Bl/6
mice. Blood were taken from the donor mice before peak of
parasitaemia and experimental mice were infected by injecting 10
5
infected erythrocytes intraperitoneally (i.p). Parasitaemia was
monitored by examination of Giemsa-stained blood films as
previously described [10]. After 45 days of the primary infection,
some mice were re-challenged i.p. with 10
5 infected erythrocytes.
Antibodies and reagents
Antibodies used were CD19-allophycocyanin (APC) and Biotin,
CD138-phycoerythrin (PE), IgM-PE and PerCP-Cy5.5, CXCR4-
Biotin, CXCR5-Biotin and GL7-fluorescein isothiocyanate (FITC)
(BD Pharmingen), IgD-PE and Biotin, MHC class II-Biotin and
B220-APC (eBioscience). Biotinylated antibodies were revealed
with streptavidin peridinin chlorophyll protein (PerCP) (BD
Biosciences) and streptavidin eFluor
TM 450 (eBioscience). Anti-
Fc receptor and Rat IgG2b’k FITC, Rat IgG2a’k PE, Rat
IgG2a’k biotin, Rat (lavian) IgMk isotype controls were purchased
from BD Pharmingen.
Multi-parametric flow cytometry analysis
Single cell suspensions of spleen, bone marrow from two femurs
and heparinised peripheral blood were prepared in complete
Iscove’s medium containing 10% fetal calf serum (FCS),
100 units/ml of penicillin, 100 mg/ml of streptomycin, 1 mM of
L-glutamine, 12 mM of Hepes (all purchased from Sigma, UK)
and 5610
25 M of 2-mercaptoethanol (Invitrogen). Erythrocytes
were lysed with red cell lysing buffer (Sigma). Lymphocytes were
counted and aliquoted at 1610
6 cells/well in 96-well V-bottom
plates. Surface staining and washing steps were done with FACS
buffer (PBS containing 2% FCS, 5 mM EDTA and 0.01% NaN3).
To prevent non-specific binding of monoclonal antibodies to the
Fc receptors, 25 ml/well Fc receptor-block was added to the cells
and incubated for 10 min on ice. Cells were then incubated for
20 min at 4uC with antibodies to detect GL7
+ populations,
transitional B cells, memory/isotype-switched B cells and plasma
cells. Cells were then washed twice and fixed overnight with 2%
paraformaldehyde in PBS. Data were acquired on a FACS
Calibur using Cell Quest Pro (Becton Dickenson) and analysed
using FlowJo (Treestar Inc.).
Preparation of recombinant MSP121
Recombinant MSP1 protein (MSP121,a a4960–5301) from P.
chabaudi chabaudi AS was expressed as his-tagged protein in Pichia
pastoris SMD1168, as previously described [20], and purified by
binding to a nickel-nitrilotriacetic acid (Ni-NTA) agarose column
(Qiagen, Hilden, Germany) and eluted with 250 mM imidazole.
ELISpot Assay for Merozoite surface protein-1 (MSP1)-
specific plasma cells
MSP1 antigen-specific plasma cells were quantified by direct ex
vivo ELISpot assay based on their ability to continuously secrete
antibody [21]. 96-well Multi-screen HA Nitrocellulose filtration
plates (Millipore) were coated with 50 mlo f1 0mg/ml recombinant
MSP1 diluted in PBS. As a positive control for total IgG secreting
cells, some wells on each plate were coated with goat anti-mouse
IgG (Caltag). The plates were incubated at 4uC overnight, washed
twice in PBS, then blocked with 200 ml complete Iscove’s medium
for 1 h at room temperature. The plates were then washed twice
with PBS and cell suspensions added at the following numbers:
3.5610
5, 1.2610
5, 3.9610
4 and 1.3610
4 per well in 100 ml
complete Iscove’s medium. The plates were incubated at 37uC,
7% CO2 for 5 h, then washed twice in PBS and twice with PBS
with 0.1% Tween (PBS-T). 100 ml of goat anti-mouse IgG biotin
conjugated antibody (Caltag) diluted 1:1000 in PBS-T containing
1% FCS was added and the plates incubated overnight at 4uC.
Plates were washed four times with PBS-T, and 100 mlo f5mg/ml
alkaline phosphatase avidin D diluted in PBS-T containing 1%
FCS added and incubated for 1 h in the dark at room
temperature, followed by two washes with PBS-T and two washes
with PBS. Detection was carried out by adding 100 ml of BCIP/
B Cells and Plasma Cells in Mouse Malaria
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until blue spots appeared. The reaction was stopped by thorough
washing with cold tap water and air-dried. Plates were analysed
using the ImmunoSpot reader, (CTL).
ELISpot Assay for MSP1-specific memory B cells
Memory B cells were detected using a modification of the
plasma cell ELISpot previously described [21]. In brief, replicates
of three-fold dilutions of cell suspensions of spleen, blood and bone
marrow were made on flat-bottomed 96-well plates (Costar), in
replicates of 22 wells for each dilution, and cultured for 6 days in
200 ml complete Iscove’s medium containing 0.4 mg R595
lipopolysaccharide (Alexis Biochemicals), 1610
6 irradiated (1,200
rad) naive splenocytes and 20 ml of supernatant from concanavalin
A-stimulated splenocytes, prepared as previously described [22].
Cells were harvested and transferred to 96-well Multi-screen HA
Nitrocellulose filtration plates and an ex-vivo ELISpot assay for
MSP1-specific plasma cell detection performed as described
above. The frequencies of MSP1-specific memory B cells were
determined from the zero order term of the Poisson distribution,
using least squares method of curve fit. The goodness-of-fit curve
was analysed by linear regression where r
2 values greater than 0.8
were accepted.
Statistics
Experiments were analysed using the Mann Whitney non-
parametric test on Prism 5 software (GraphPad Software Inc.) and
p#0.05 considered significant.
Results
Changes in total PBMC, B cells and plasma cells occur in
blood during a Plasmodium chabaudi infection
In order to compare the phenotypes and numbers of malaria-
specific B cell- and plasma cells (PC) in PBMC with those in
spleen and bone marrow, we first determined the changes in total
cellularity in these organs during a Plasmodium chabaudi blood-
stage infection. Substantial changes in the total cellularity and
overall composition of B cells and PC are known to take place in
spleen and bone marrow during blood-stage rodent malaria
infections [2–6,23–25]. In agreement with these studies, we
observed a large increase in total cell numbers in the spleen
following the peak of parasitaemia, and a transient drop in
numbers in the bone marrow just before and at the peak of
parasitaemia (Figure 1A). The numbers of PBMC in blood,
however, increased transiently only at peak parasitemia and then
return to levels of naı ¨ve mice by day 20 and for the remainder of
the infection (Figure 1A). CD19
+ B cell numbers in blood did not
alter substantially during a primary P. chabaudi infection
(Figure 1B). By contrast, we observed a 2.5-fold increase in
CD19
+ B cells on day 25 of infection and a depletion of CD19
+ B
cells from the bone marrow at peak parasitaemia. Simlarly,
CD138
+ PC were present only transiently in blood just before
and at the peak of parasitaemia (day 5 and 10), and in very low
numbers (less than 5% of PBMC; Figure 1C). There was a
transient increase in CD138
+ cells between days 5 and 25 in the
spleen during the primary infection. In bone marrow, we
observed a bi-modal pattern with a transient peak on Day 5,
and a more sustained increase from day 45 onwards. The kinetics
of CD138
+ cells in peripheral blood was similar during a
secondary infection. This suggests that timing of blood sampling
during the peak of infection, even in individuals who have had
multiple exposures, may be critical for detecting malaria-specific
PC.
Transitional, mature naive and memory B cell
populations are detected in blood, spleen and bone
marrow during a P. chabaudi infection
Memory B cells are mostly contained within the CD19
+ IgM
2
IgD
2 isotype-switched population of B cells [26–28]. To gain an
idea of the expected frequency of all ‘‘memory’’ or isotype-
switched B cells in peripheral blood during infection compared
with spleen, we investigated surface IgM and IgD expression on
CD19
+ B cells by flow cytometry. Based on the relative surface
expression of IgM and IgD, transitional, mature naı ¨ve and isotype-
switched B cells can also be distinguished within the CD19
+
populations ([29]. Here, IgD
low expressing cells are defined as
early transitional B cells (T1), although in the spleen this
population may also include marginal-zone B cells. IgD
high
IgM
high expressing cells are designated as late transitional B cells
(T2), IgD
intermdiate (int) IgM
low as mature naı ¨ve B cells, and IgD
2
IgM
2 as isotype-switched B cells, that is, memory or antigen-
experienced B cells [29] (as shown in Figure 2A).
During a primary P. chabaudi infection, all subpopulations of B
cells; T1, T2, mature naı ¨ve and isotype-switched were observed in
peripheral blood, although their numbers and proportions differed
from those in spleen (Figure 2B). Most importantly, the proportion
of isotype-switched B cells were only a small proportion of B cells
in the blood (less than 10% of B cells, except on day 5 when
approximately 20% of B cells had switched), in marked contrast to
the spleen, where they comprised 25%-50% of the B cells between
days 10 and 45 of infection.
Memory B cells are not thought to reside in the BM [30] and
CD19
+ IgM
2 IgD
2 cells in bone marrow are considered to be
pro- and pre-B cells [29,31–33]. In naı ¨ve mice and for most of the
primary P. chabaudi infection these cells comprised the largest
fraction (.50%) of CD19
+ cells in BM. Notably, at day 10 of
infection, just after peak parasitemia, this immature B cell
population was drastically reduced compared with the numbers
at day 5 or day 25 (Figure 2B, right panel; Mann Whitney
p,0.001). This suggests that immature B cells had been exported
from the BM or undergone cell death in large numbers, or that
hematopoesis leading to the production of pro- and pre-B cells was
severely depressed at the peak of infection.
During a secondary infection with P. chabaudi, other than a drop
in total numbers, and particularly in mature naive B cell numbers,
in all organs at day 9, the relative proportions of the different
subpopulations do not appear to alter significantly. Interestingly,
with the exception of day 9, the numbers and proportions of all the
B cell subpopulations remain very stable during an acute
secondary infection, with memory B cells comprising less than
5% of B cells at any time tested. Therefore circulating memory B
cells remain at very low frequencies even during a secondary
infection.
GL7 is expressed mainly on immature B cells in the blood
during a P. chabaudi infection
Another marker used to distinguish antigen-experienced B cells
is GL7 [34,35]. This cell surface protein is expressed at high levels
on early pre-B cells, downregulated on mature naive B cells, and
then upregulated and highly expressed on germinal centre and
post-germinal centre B cells that have undergone affinity
maturation and/or isotype switching [35,36]. Following a primary
P. chabaudi infection, the proportion and numbers of total GL7
+
CD19
+ B cells in PBMC were greater than those of total isotype-
switched B cells as described in Figure 2, indicating that GL7
expression on PBMC was not identifying exclusively isotype-
switched B cells. Indeed, we found that GL7 was expressed mainly
B Cells and Plasma Cells in Mouse Malaria
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migrated from the bone marrow. In the spleen, GL7 expression
was predominantly on isotype-switched B cells (Figure 3B), in
agreement with previous studies [34,37]. In bone marrow, GL7
was expressed on pre-B cells as described previously [34,37].
Because of the expression of GL7 on immature B cells appearing
in peripheral blood during a primary and secondary infection,
GL7 cannot be used as a marker for memory B cells in PBMC.
MSP1-specific IgG memory B cells can be detected in
peripheral blood of infected mice ten days following
infection and are maintained for a long time
The persistently low frequency of memory B cells in peripheral
blood detected by flow cytometry suggested that the frequency of
detectable malaria-specific B cells might be very low. We used an
ELISpot assay to detect MSP1-specific IgG MBC during primary
and secondary infection (Figure 4). In line with the low frequency
of isotype-switched MBC, the frequency of MSP1-specific IgG
MBC in PBMC as determined by ELISpot was also very low but
consistent from day 10 of a primary infection onwards (Figure 4,
top left graph, ,12 MSP1-specific IgG MBC per ml of blood).
This was markedly lower than the numbers seen per spleen, which,
as described previously [38], peaked at day 10 of infection (figure 4,
bottom left graph, approximately 1500 MSP1-specific IgG MBC
(per spleen), then contracted (approximately 500 per spleen) and
persisted for up to day 90. Thus MBC in peripheral blood can be
detected in low numbers after peak parasitaemia, but do not reflect
the kinetics of MBC in the spleen.
After a secondary infection, there was a 3.5-fold increase in
numbers of MSP1-specific MBC in the spleen at day 10 (Figure 4,
bottom right graph, from 500 to 1700 per spleen).A 5-fold increasein
Figure 1. Changes in B-cell and plasma-cell number in different compartments. C57BL/6 mice were injected intraperitoneally with 10
5
Plasmodium chabaudi chabaudi (AS) iRBC and the infection course followed. A) Total PBMC in peripheral blood (red), spleen (black) and bone marrow
(two femurs; blue) at different time points following a primary infection; B) CD19
+ B cells determined by flow cytometry following a primary infection;
C) Numbers of CD138
+ plasma cells/plasmablasts determined by flow cytometry following a primary (upper panel) and secondary infection (lower
panel). Gating strategies for CD19
+ and CD138
+ cells are shown in Figure S1. The values and error bars shown are the means and the standard errors
of the mean (SEM) of 5 to 7 mice.
doi:10.1371/journal.pone.0015007.g001
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10, albeit at a much lower frequency (Figure 4, top right graph, from
15 to 60 per ml of blood) and resuming previous levels by day 20.
MBC could not be detected at significant levels at any time in
the BM (data not shown).
These data suggest that the secondary MSP1-specific MBC
response in the spleen has taken place very early following re-
infection, and by day 20 these cells have most likely died or have
differentiated into short-lived plasma cells. Although there was no
increase of MBC at day 20 in the blood or bone marrow, it is
possible that the MBC have been redistributed to other tissues or
lymphoid organs. In blood, whilst frequencies of MSP1-specific
MBC remained low throughout primary infection, there was a
significant increase in MSP1-specific MBC in blood at the peak of
a secondary infection, perhaps reflecting the migration of some
MSP1-specific MBC out of the spleen.
MSP1-specific IgG antibody-secreting cells can be
detected in peripheral blood within a narrow window of
time post-infection
The transient appearance of plasma cells detected at the peak of
parasitaemia by flow cytometry could reflect a Plasmodium-specific
plasma cell response. As described above for MBC, we could not
determine the fraction of MSP1-specific plasma cells/plasmablasts
by this method and therefore used an MSP1-specific ELISpot
assay to enumerate MSP1-specific IgG antibody-secreting cells
(ASC) (plasma cells and plasmablasts).
The numbers of MSP1-specific IgG ASCs in peripheral blood
following a primary infection could only be detected between days
10 and 25 and were extremely low (Figure 5 left graph, top panel,
approximately 5 per ml) compared with either spleen (2610
4)o r
BM (3610
3) (Figure 5, middle and bottom panels). However, there
was a transient but large increase of MSP1-specific IgG-ASCs in
peripheral blood (Figure 5, right graph, top panel, approximately
4000 per ml) on day 10 following a secondary infection.
In spleen, maximum numbers of MSP1-specific IgG ASCs were
observed at day 10 of the primary infection (Figure 5, left graph,
middle panel) and reducing to barely detectable levels by day 45.
After a secondary infection, there was a rapid increase in the
numbers of MSP1-specific IgG ASCs numbers at day 10, which
persisted for up to 30 days (Figure 5, right graph, middle panel).
No MSP1-specific IgG ASCs were detected in the BM at day 10
of primary infection, only appearing in detectable frequencies
from day 25 onwards (Figure 5, left graph, bottom panel). There
was no further increase in the number of MSP1-specific IgG ASC
during a secondary infection (figure 5, right graph, bottom panel).
Figure 2. Changes in subpopulations of B cells in different compartments. A) Gating strategy for the identification of transitional T1 (IgM
high
IgD
low), T2 (IgD
high IgM
high), naı ¨ve B cells (IgD
intermdiate (int) IgM
low) and switched B cells (IgM
2IgD
2) on CD19
+ B cells. B) Numbers of the different
subpopulations of B cells were determined by flow cytometry following a primary and secondary infection of Plasmodium chabaudi chabaudi (AS).
The values and error bars shown are the means and the standard errors of the mean (SEM) of 5 to 7 mice.
doi:10.1371/journal.pone.0015007.g002
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window of time following infection when malaria-specific ASCs
are found in peripheral blood, and, taken with the kinetics of
plasma cells in spleen and bone marrow, reflect the migration of
malaria-specific plasma cells from the spleen to the bone marrow.
CD138
+ antibody secreting cells in peripheral blood are
migrating plasmablasts
Plasma cells in peripheral blood have two potential sources;
either they are newly differentiated plasmablasts migrating from
the lymphoid organs to the become long-lived PC in the bone
marrow (LLPC), or they could be pre-existing LLPC that have
been dislodged from their bone marrow niche by the newly
migrating PC [16,39,40]. If numbers of ASC in peripheral blood
are to be used as an indication of an ongoing humoral response
and development of plasma cells, then it is important that we can
differentiate between these two possibilities. LLPC dislodged from
bone marrow are unable to re-home to survival niches and die
within two weeks in circulation [41]; it is unlikely that they
contribute to ongoing humoral responses.
Newly differentiated migratory plasmablasts and LLPC can be
distinguished by the co-expression of the cell surface molecules
B220 and CD138 (Figure 6A), in conjunction with the relative
expression of other surface molecules like CD19 and MHC class
II. Plasmablasts are CD138
+ B220
+ and express higher levels of
MHC class II and CD19, whereas mature bone marrow plasma
cells have downregulated CD19, B220 and MHC class II
expression. In addition, the chemokine receptor CXCR4 is
upregulated as B cells differentiate through plasmablasts and is
maintained on bone marrow LLPC, whereas expression of
CXCR5 is down regulated as B cells differentiate into plasmablasts
[19,42–44].
We assessed the expression of these molecules on the surface of
plasma cell populations in blood, spleen and bone marrow defined
by CD138 and B220 expression (Figure 6A). Plasma cells in
peripheral blood at day 10 a primary or secondary infection. The
majority of CD138
+ PC in blood in a primary infection expressed
B220 typical of plasmablasts, and thus more resembling the cells
emigrating from the spleen than PC being displaced from bone
marrow (Figure 6A; left panel). This was also observed during a
secondary infection (data not shown). A more detailed analysis at
day 10 of a primary (Figure 6B) or secondary infection (data not
shown), which revealed a distinct shift in the expression of CD19,
MHC class II, CXCR4 and CXCR5 between splenic B220
+ cells
and CD138
+ cells in spleen, blood and bone marrow. CD19 was
downregulated on all CD138
+ cells compared with splenic B220+
cells, with the greatest reduction on CD138
+ B220
2 LLPC in bone
marrow. Similarly, MHC class II and CXCR5 expression was
lowest on these cells. Conversely, CXCR4 was upregulated on
CD138
+ cells compared with splenic B220
+ cells, and was highest
on bone marrow CD138
+ B220
2 LLPC. Thus it appears that
there is a gradual acquisition or loss of the markers as B cells
Figure 3. GL7 is expressed mainly on transitional B cells in blood during infection. A) Gating strategy for the identification of GL7
+ CD19
+ B
cells in peripheral blood (left), spleen (middle) and bone marrow (right). B) The number of CD19
+ B cells expressing GL7 on different subpopulations;
transitional T1 (IgM
highIgD
low), T2 (IgD
highIgM
high), naı ¨ve B cells (IgD
intermdiate (int)IgM
low) and isotype-switched B cells (IgM
2IgD
2) determined by flow
cytometry. The values and error bars shown are the means and the standard errors of the mean (SEM) of 5 to 7 mice.
doi:10.1371/journal.pone.0015007.g003
B Cells and Plasma Cells in Mouse Malaria
PLoS ONE | www.plosone.org 6 November 2010 | Volume 5 | Issue 11 | e15007differentiate into LLPC. The CD138
+ cells in blood at the peak of
a primary or secondar infection were intermediate in this pathway,
strongly supporting the idea that they are newly differentiated
migratory plasmablasts. We therefore conclude that the transient
appearance of CD138
+ cells in the peripheral blood at the peak of
infection is due to plasmablasts generated by the primary or
secondary response migrating to the bone marrow niches to
become LLPC. Therefore, the MSP1-specific IgG ASC response
detected by ELISpot as described in Figure 5 is likely to be part of
an ongoing malaria-induced immune response rather than
dislodged bone marrow LLPC and in this respect sampling of
blood can be used to detect a malaria-induced PC response during
infection.
Discussion
Analysis of immune responses in humans requires the use of
PBMC as a source of lymphocytes and myeloid cells, which may
not always reflect the ongoing or memory responses, particularly
during or following infections such as malaria, when reactive cells
are likely to be located in the appropriate secondary lymphoid
organs [2–6,45]. This is a pertinent issue when using PBMC to
analyse the B cell and plasma cell responses following immuni-
sation or infection, as B cell responses take place in lymphoid
organs, and plasma cells generally reside primarily in bone
marrow, but also in other lymphoid organs and inflamed tissues.
Here we have asked how far the composition of total B cells and
plasma cells, and the numbers of MSP1-specific memory B cells
and antibody-secreting cells in PBMC during and after a P.
chabaudi infection in the mouse reflect those of spleen and bone
marrow (the major site of induction of the B cell response and the
location of long-lived plasma cells, respectively). Although the
MSP1-specific B cell response may not be reflective the total B cell
response to all P. chabaudi antigens, our data suggest that P.
chabaudi-induced memory B cell and PC/ASC responses in blood
do not consistently represent ongoing responses in the lymphoid
organs, but can be reflective of the appropriate organs if the timing
of sampling coincides with cell migration or trafficking.
Isotype-switched or antigen-experienced memory B cells,
defined phenotypically here as CD19
+ IgD
int IgM
low, are found
in peripheral blood only at low frequency following a primary and
secondary infection, but are still detectable for several weeks or
months afterwards. in this respect similar to the presence of
isotype-switched B cells in the spleen. MSP1-specific memory B
cells in blood, determined by a functional ELISpot assay, are also
present at very low but detectable levels for similar periods of time,
and present in increased numbers following a second infection;
again with similar kinetics, but not magnitude, to the response of
splenic memory B cells, and remain at persistently low but
detectable levels for up to 90 days after a primary infection. These
observations are in agreement with human studies, where in areas
of extremely low transmission, and many years after a single
exposure, P. falciparum-specific MBC could be detected in
peripheral blood in low numbers [46]. The results from two
vaccination studies are similarly encouraging, demonstrating the
generation of long-lived memory B cell responses in the blood
[47,48]. It is interesting to note that the P. falciparum-specific MBC
compartment has been observed to increase with age in children
and adults, indicating that there might be a delayed acquisition of
natural immunity to malaria in humans, while MBCs specific to
Figure 4. MSP1-specific IgG memory B cells are detectable in peripheral blood in low numbers. The frequencies of MSP1-specific IgG
memory B cells were determined by in vitro cultured ELISpot assays as described in the experimental procedures. The frequencies of MSP1-specific
IgG memory B cells in peripheral blood and spleen following both a primary and secondary infection are presented as memory B cells per ml of blood
and per spleen respectively. The values and error bars shown are the means and the standard errors of the mean (SEM) of 5 to 7 mice.
doi:10.1371/journal.pone.0015007.g004
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to stabilise rapidly after vaccination and subsequently remain
constant regardless of age [49,50]. It is important to note that
memory B cells and long-lived plasma cells represent independent
arms of humoral immunity, and persistence of specific memory B
cells in peripheral blood alone may not correlate with the longevity
of specific humoral immunity [51].
Regarding the fate of MSP1-specific MBC during a secondary
infection, the significantly higher frequency of memory B cells at
day 10 of a secondary infection, followed by a reduced frequency
by day 20, may reflect the differentiation of these cells into short-
lived plasma cells after antigen stimulation [52,53] as most early
post-germinal centre memory B cells have a limited lifespan [14]
as suggested by accompanying increase in ASC in the spleen this
time of the secondary P. chabaudi infection. It is possible that
MSP1-specific memory B cells die in the spleen as a result of a
secondary P. chabaudi infection, as we did not observe an increase
in MSP1-specific MBC in the blood or increase in plasma cells in
the blood or bone marrow following the decline in MBC in the
spleen after day 10 of the secondary infection. This is in line with a
previous study demonstrating P. yoelii-induced apoptosis of pre-
established MSP1-specific memory B cells in the spleen [54].
The very low numbers of specific memory B cells persisting in
blood is very much in line with studies on human B memory cell
responses in malaria endemic areas. For some Plasmodium antigens
there were no, or very low intermittent memory B cells detectable
[49,55], and these are often undetectable outside of the
transmission season. These findings have been interpreted as a
defective or short-lived memory B cell response, but it may simply
reflect the low frequencies of persisting, circulating memory B cells
and the slow acquisition of malaria immunity. That there are
significant numbers of specific memory B cell still present in mice
in 6 weeks post infection is exemplified here by the relatively rapid
increase in ASC in blood and in spleen [38] shortly after a
secondary infection. It is interesting that the percentage of
peripheral blood MBC which we observed in mice (less than 5%
of total B cells) during primary and secondary infection is lower
than that typically found in humans. This may reflect the very
clean environment in which laboratory mice are housed compared
with the exposure of humans to many pathogens and environ-
mental antigens which can expand the MBC pool over time.
Many antibody reagents used to define the developmental status
of B cells or plasma cells have been characterised in ‘‘steady state’’
or after immunisation, and not during long-lasting or repeated
infection. Several groups including our own have shown that have
shown that immunisation and infection with Plasmodium or other
pathogens transiently suppress and/or alter bone marrow
haematopoesis [24,56], which is followed by an increase in export
Figure 5. MSP1-specific IgG antibody-secreting cells (ASC) appear transiently in peripheral blood during infection. The frequencies of
ASC were determined by direct ELISpot assays as described in the experimental procedures. The numbers of MSP1-specific IgG ASC in peripheral
blood, spleen and bone marrow following both a primary and secondary infection are presented as ASC per ml of blood, per spleen and per two
femurs respectively. The values and error bars shown are the means and the standard errors of the mean (SEM) of 5 to 7 mice.
doi:10.1371/journal.pone.0015007.g005
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+ immature B cells [57]. In
agreement with these previous studies demonstrating the accu-
mulation of RAG
+ immature B cells in spleen and blood following
administration of adjuvants or infection, we show here that during
an acute primary blood-stage P. chabaudi infection there was an
increase in the numbers of immature T1 and T2 B cells in both
blood and spleen, whereas there was a transient decrease in these
cells in bone marrow.
The GL7 marker is often used in mice to delineate CD19
+ B
cells that had undergone a germinal centre reaction [35,36] and
which will differentiate into plasma cells [34]. However GL7 is
also expressed on early developing B cells in the bone marrow
[34]. Since the numbers of immature B cells increases in blood and
spleen after an acute P. chabaudi infection, and GL7 expression is
found predominantly on T1 and T2 B cells particularly in blood,
the expression of this molecule cannot be used to define B cells that
have undergone maturation in germinal centres. As the presence
of immature T1 and T2 B cells have also been described in human
peripheral blood [58], it will be important when translating these
observations to human infections to define memory or germinal-
centre experienced B cells using several markers besides GL7 and
using functional assays to ensure that immature B cells are not
included.
The large number of immature B cells in the circulation or in
the spleen can have a role in altering the outcome of the B cell
response, as immature B cells are highly susceptible to tolerance
[59,60] and therefore unlikely to develop into memory cells [56].
This may be another explanation for the very low frequency of
total and MSP1-specific memory B cells amongst PBMC observed
by flow cytometry and ELISpot in this study and in studies on
malaria-exposed humans, Here we have only measured one P.
chabaudi Ag; it is also possible that the overall frequency of all
malaria specific MBC and ASC is normal.
Plasma cells either defined by expression of CD138, an
adhesion/growth factor receptor [61] or as MSP1-specific IgG
ASC, were detected in blood at very low frequencies, and only
very transiently (approximately 10 days after primary and
secondary infection), in stark contrast to memory B cells, which
were detectable in PBMC at all the time points sampled.
[62]There was also a sharp transient increase in plasma cells in
peripheral blood around day 10 of the secondary infection. In both
primary and secondary infections, the MSP1-specific ASC
mirrored the CD138
+ PC in kinetics, but at substantially lower
frequencies. In contrast, the dynamics of total PC in bone marrow
was different; CD138
+ PC accumulated and were present for up to
90 days (the period of observation), whereas MSP1-specific ASC
were observed for up to 20 days after secondary infection (the
period of observation).
Our observations fit well with previous studies demonstrating
human and mouse plasma cells in blood 7 to 10 days after
immunisation [17,63,64], and support the idea that this transient
appearance of PC in blood represents the normal migration of PC
after antigen stimulation and B cell differentiation. It has been
previously described that most plasma cells move from their
lymphoid organ to the bone marrow within one week to 10 days
after B cell activation and differentiation [65], after which PC/
ASC lose their ability to migrate and die [66].
It is possible that CD138
+ cells and MSP1-specific ASC in blood
may not be only plasmablasts migrating from lymphoid organ to
bone marrow [16,39,44], but may also represent PC lost from
bone marrow through ablation of the niche, or displaced through
competition for the niche by new plasmablasts developing from
memory B cells. Ascertaining the origin of the plasma cells
detected in peripheral blood of malaria-infected humans would
therefore be important in shedding light on whether plasma cell
dislodgement is a phenomenon associated with malaria infection
and hence another explanation for the short-lived antibody
responses observed in endemic areas. Once dislodged, these
plasma cells do not have the adequate potential for relocating
efficiently and are thus not indicative of a developing immune
response [16]. Encouragingly for human studies, the majority of
CD138
+ PC in PBMC in this P. chabaudi infection were newly
differentiated migratory plasmablasts expressing intermediate
levels of CXCR4, B220, CD19 and MHC class II [17] suggesting
that they were indeed from the spleen and migrating to the BM via
the peripheral blood, and thus immunologically relevant and likely
to form part of the pool of long-lived plasma cells in the BM.
The results from this study of an experimental rodent malaria
infection are encouraging, since they show that to some extent
peripheral blood PBMC can be used to reflect malaria-induced B
cell responses the spleen, particularly to detect plasmablasts
destined for the long-lived survival niches in the BM. Although
the exact timing of appearance of PC/ASC between mice and
humans are unlikely to be the same, our study emphasises the need
for proper study design when peripheral blood is used. It is
important that time points selected for sample collection include
the ‘‘windows’’ within which cells of interest are expected to be
circulating in peripheral blood.
Supporting Information
Figure S1 Gating strategies for CD19
+ and CD138
+ cells
in blood, spleen and bone marrow. Single cell suspensions
from mice on day 10 of a Plasmodium chabaudi chabaudi (AS)
infection were prepared as described in Materials and Methods.
The red line shows the gated regions for live cells (A), CD19
+ and
CD138
+ cells (B) and isotype controls (C). The numbers indicate
the percentage of each gated population.
(TIF)
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Figure 6. Antibody-secreting cells in peripheral blood are migrating plasmablasts. A) Gating strategy for the identification of plasmablasts
and long-lived plasma cells (LLPC) in peripheral blood, spleen and bone marrow on day 10 of infection. B) Histograms showing relative expression of
CXCR4, CD19, MHC class II and CXCR5, on spleen (top two panels), blood (middle panel) and bone marrow (bottom two panels). Differences between
plasma cells and plasmablasts were determined by the mean fluorescence intensity of these markers on the gated populations (red histograms)
showing the gradual acquisition of CXCR4 and loss of CXCR5, CD19, MHC class II on splenic B220
+ cells (top panel), B220
+ CD138+ cells in spleen,
blood and bone marrow (middle three panels) and B220
2 CD138
+ LLPC in bone marrow (bottom panel). The blue histograms represent the
fluorescence profile with the isotype control antibodies. C) A representative experiment out of 3 experiments showing kinetics of the appearance of
plasma cells and plasmablasts during peak of infection based on their expression of B220 and CD138. The values and error bars shown are the means
and the standard errors of the mean (SEM) of 5 mice.
doi:10.1371/journal.pone.0015007.g006
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